SCHEMBL17040872

SCHEMBL17040872

c1ccc(-c2ccc3c4ccc(-c5ccccc5-c5ccccc5N(c5ccccc5)c5ccccc5)cc4n(-c4ccccc4)c3c2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
KDM4E B2RXH2 1/20 0.36
METAP2 P50579 1/20 0.34
AVPR1A P37288 1/20 0.33
TSPO P30536 1/20 0.32
MEN1 O00255 1/20 0.32
APAF1 O14727 1/20 0.32
NPC1 O15118 1/20 0.32
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32
THRB P10828 1/20 0.32
XBP1 P17861 1/20 0.32
PTBP1 P26599 1/20 0.32
HTT P42858 1/20 0.32
RAB9A P51151 1/20 0.32
GALK1 P51570 1/20 0.32
BLM P54132 1/20 0.32
SMAD3 P84022 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17040887 0.95 TSPO (0.37) ATML3MBTL1KDM4EMETAP2AVPR1A
SCHEMBL17056701 0.95 ATM (0.38) ATML3MBTL1KDM4EMETAP2AVPR1A
SCHEMBL18561158 0.94 L3MBTL1 (0.43) ATML3MBTL1KDM4EMETAP2AVPR1A
SCHEMBL17040868 0.93 L3MBTL1 (0.40) ATML3MBTL1KDM4EMETAP2TSPO
SCHEMBL17040873 0.93 L3MBTL1 (0.44) ATML3MBTL1KDM4EMETAP2AVPR1A
SCHEMBL17040890 0.92 L3MBTL1 (0.46) ATML3MBTL1KDM4EMETAP2TSPO
SCHEMBL16947082 0.92 ATM (0.38) ATML3MBTL1KDM4EMETAP2AVPR1A
SCHEMBL17041527 0.92 L3MBTL1 (0.41) ATML3MBTL1KDM4EMETAP2TSPO
SCHEMBL17040891 0.92 L3MBTL1 (0.41) ATML3MBTL1KDM4ETSPOMEN1
SCHEMBL17040894 0.91 KDM4E (0.40) ATML3MBTL1KDM4EMETAP2TSPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10700285-B2 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2020-06-30 US disclosed
US-20170062728-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2017-03-02 US disclosed
US-20170062728-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2017-03-02 US disclosed
WO-2015126090-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME AND ELECTRONIC DEVICE THEREOF 덕산네오룩스 주식회사 2015-08-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170062728-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF GPX1, OR51E2, PIEZO1 ATM 4174/4885L3MBTL1 297/4885KDM4E 984/4885
US-10700285-B2 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof GPX1, OR51E2, PIEZO1 ATM 4174/4885L3MBTL1 297/4885KDM4E 984/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.